Antifibrinolytic Agents (Systemic)
Category- Antifibrinolytic
- Antihemorrhagic - Aminocaproic Acid; Tranexamic Acid
DescriptionAntifibrinolytic (an-tee-fye-bri-noh-LIT-ik) agents are used to treat serious bleeding, especially
when the bleeding occurs after dental surgery (particularly in patients with
hemophilia) or certain other kinds of surgery. These medicines are also sometimes
given before an operation to prevent serious bleeding in patients with medical
problems that increase the chance of serious bleeding.
Antifibrinolytic agents may also be used for other conditions as determined
by your doctor.
Antifibrinolytic agents are available only with your doctor's prescription,
in the following dosage forms:
Oral
-
Aminocaproic acid
-
Syrup (U.S. and Canada)
-
Tablets (U.S. and Canada)
-
Tranexamic acid
-
Tablets (U.S. and Canada)
Parenteral
-
Aminocaproic acid
-
Injection (U.S. and Canada)
-
Tranexamic acid
-
Injection (U.S. and Canada)
Brand NamesSome commonly used brand names are:
In the U.S. -
In Canada -
Another commonly used name for aminocaproic acid is epsilon-aminocaproic acid
.
This information applies to the following medicines: |
1. |
Aminocaproic Acid (a-mee-noe-ka-PROE-ikASS-id)‡ |
2. |
Tranexamic Acid (tran-ex-AM-ik ASS-id) |
‡ Generic name product may be available in the U.S. |
|